Adult neurogenesis in the hippocampus is impaired in schizophrenic patients and in an animal model of schizophrenia. Amongst a plethora of regulators, the immune system has been shown repeatedly to strongly modulate neurogenesis under physiological and pathological conditions. It is well accepted, that schizophrenic patients have an aberrant peripheral immune status, which is also reflected in the animal model. The microglia as the intrinsic immune competent cells of the brain have recently come into focus as possible therapeutic targets in schizophrenia.
Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia 
a b s t r a c t
Adult neurogenesis in the hippocampus is impaired in schizophrenic patients and in an animal model of schizophrenia. Amongst a plethora of regulators, the immune system has been shown repeatedly to strongly modulate neurogenesis under physiological and pathological conditions. It is well accepted, that schizophrenic patients have an aberrant peripheral immune status, which is also reflected in the animal model. The microglia as the intrinsic immune competent cells of the brain have recently come into focus as possible therapeutic targets in schizophrenia.
We here used a maternal immune stimulation rodent model of schizophrenia in which polyinosinicpolycytidilic acid (Poly I:C) was injected into pregnant rats to mimic an anti-viral immune response. We identified microglia IL-1b and TNF-a increase constituting the factors correlating best with decreases in net-neurogenesis and impairment in pre-pulse inhibition of a startle response in the Poly I:C model. Treatment with the antibiotic minocycline (3 mg/kg/day) normalized microglial cytokine production in the hippocampus and rescued neurogenesis and behavior. We could also show that enhanced microglial TNF-a and IL-1b production in the hippocampus was accompanied by a decrease in the pro-proliferative TNFR2 receptor expression on neuronal progenitor cells, which could be attenuated by minocycline. These findings strongly support the idea to use anti-inflammatory drugs to target microglia activation as an adjunctive therapy in schizophrenic patients.
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Introduction
Schizophrenia is a devastating disorder and constitutes a social and economic burden for patients as well as families and society. During the past decades, an increasing number of studies have associated schizophrenia and inflammation (Müller and Schwarz, 2010; Fineberg and Ellman, 2013) . Concomitantly, microglia cells -the intrinsic immune competent cells of the brain -have been pinpointed in the pathophysiology of this neurodevelopmental disorder in both human patients and animal models of this disorder (Blank and Prinz, 2013; Fricker et al., 2013; Harry and Kraft, 2012) . In a subpopulation of schizophrenic patients increased microglial cellular density and activity has been found in postmortem tissue and in vivo (Falkai et al., 1999; Steiner et al., 2006; van Berckel et al., 2008; Busse et al., 2012) as well as in animal models of schizophrenia with varying results depending on brain region and age investigated (Juckel et al., 2011; Garay et al., 2013; van den Eynde et al., 2014) .
One way in which activated microglia contribute to pathology is through the production of pro-inflammatory cytokines. An imbalance in cytokine levels may trigger aberrant neurodevelopment in the fetus and lead to neuropathology and psychopathology in the adult offspring. Infection-induced increase of pro-inflammatory maternal cytokines may be one of the key events leading to enhanced risk for neuropsychiatric disorders in the offspring (Gilmore and Jarskog, 1997). Human studies revealed that increased maternal serum levels of the pro-inflammatory cytokine Tumor Necrosis Factor-a (TNF-a) and the chemokine Interleukin-8 (IL-8) during pregnancy are directly associated with a higher risk for schizophrenia http://dx.doi.org/10.1016/j.bbi.2014.01.019 0889-1591/Ó 2014 Elsevier Inc. All rights reserved.
